Cargando…
Antibodies to a Full-Length VAR2CSA Immunogen Are Broadly Strain-Transcendent but Do Not Cross-Inhibit Different Placental-Type Parasite Isolates
The high molecular weight, multidomain VAR2CSA protein mediating adhesion of Plasmodium falciparum-infected erythrocytes in the placenta is the leading candidate for a pregnancy malaria vaccine. However, it has been difficult so far to generate strong and consistent adhesion blocking antibody respon...
Autores principales: | Avril, Marion, Hathaway, Marianne J., Srivastava, Anand, Dechavanne, Sébastien, Hommel, Mirja, Beeson, James G., Smith, Joseph D., Gamain, Benoît |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034725/ https://www.ncbi.nlm.nih.gov/pubmed/21326877 http://dx.doi.org/10.1371/journal.pone.0016622 |
Ejemplares similares
-
Induction of strain-transcendent antibodies to placental-type isolates with VAR2CSA DBL3 or DBL5 recombinant proteins
por: Avril, Marion, et al.
Publicado: (2011) -
VAR2CSA binding phenotype has ancient origin and arose before Plasmodium falciparum crossed to humans: implications in placental malaria vaccine design
por: Gangnard, Stéphane, et al.
Publicado: (2019) -
Var2CSA Minimal CSA Binding Region Is Located within the N-Terminal Region
por: Srivastava, Anand, et al.
Publicado: (2011) -
Phosphorylation of the VAR2CSA extracellular region is associated with enhanced adhesive properties to the placental receptor CSA
por: Dorin-Semblat, Dominique, et al.
Publicado: (2019) -
Down-selection of the VAR2CSA DBL1-2 expressed in E. coli as a lead antigen for placental malaria vaccine development
por: Chêne, Arnaud, et al.
Publicado: (2018)